GlaxoSmithKline Pharmaceuticals informs about issue of duplicate certificates

23 Jan 2020 Evaluate

Pursuant to Regulation 39 and other application regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the Regulations), GlaxoSmithKline Pharmaceuticals has informed that the Registrar and Transfer Agent of Company Kfintech has received request for issue of duplicate Share Certificates from Shareholder, Ushaben Atul Jani, Atul Shivlal Jani.

The above information is a part of company's filings submitted to BSE.


Glaxosmithkline Phar Share Price

2051.10 -26.85 (-1.29%)
07-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1515.15
Dr. Reddys Lab 6277.10
Cipla 1388.00
Zydus Lifesciences 980.65
Lupin 1610.55
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.